Article Publication Charges

All articles accepted and published in Immunity, Inflammation and Disease are fully Open Access: immediately freely available to read, download and share. 

Submissions will be subject to an APC if accepted and published in the journal: $3,240 USD / £2,060 GBP / €2,430 EUR

Society Members: $2,916 USD / £1,854 GBP / €2,187 EUR

This journal offers discounts for select article types:  

Letter, Registered Report Stage 1, Registered report Stage 2: $1,620 USD / £1,030 GBP / €1,220 EUR 

Automatic article publication charge waivers and discounts will be given to authors from countries on the Waivers and Discounts List. Authors should submit a waiver or discount request during the submission of their article.

Authors who receive funding from an agency or institution with a Wiley Open Access Account do not pay directly. The charge is paid by the institution or funder.  Please see Wiley’s information on agreements with funders and institutions and our Author Compliance Tool to find out more about what arrangements your funder may have made to pay for Open Access. More details are available here. 

The journal does not charge any submission fees or page charges.

Taxes on Publication Charges

The prices quoted do not include any value-added tax (VAT), goods and services tax (GST), or other sales taxes. Tax may be charged in addition to the price shown where required by law. The amount of tax charged will be calculated at the point of sale and identified separately.

If you have a VAT, GST, or other sales tax identification number, you should provide this when requested.

Open Access Licensing and Copyright

Immunity, Inflammation and Disease is an Open Access journal: authors of accepted articles pay an article publication charge, and their articles are published under a Creative Commons license.

All authors must use the CC BY Creative Commons License.

Certain funders mandate a particular type of CC license be used. For more information about the licenses offered by this journal, please visit Wiley Author Services.

Advertising Policy

Immunity, Inflammation and Disease accepts advertisements that are relevant to the journal’s subject community, promote high quality products and services, and are provided by reputable organizations who display a true commitment to science and medicine. This journal can earn revenue from advertising sales income.

Wiley’s advertising policy safeguards editorial autonomy and mitigates potential conflicts of interest.

Wiley advertising sales activities conform to applicable ICMJE advertising recommendations, and all advertising campaigns served against editorial content are subject to the ICMJE recommendations. Our policies align with industry standards, guidelines, and best practices. Advertisers, agencies, and partners promoting their products on Wiley platforms follow regulations set forth by the appropriate regional governing bodies.

Wiley targets advertising based on publication, taxonomy, geography, behavior, and opted-in audience demographics. User specific targeting only applies to individuals who have willingly and explicitly agreed to share their personal data as per our privacy policy. For more information about this journal’s advertising policy, please contact corpsolutions@wiley.com.